Slug, a stem cell regulator, keeps breast cells healthy by promoting repair of DNA damage

July 16, 2019

BOSTON (July 16, 2019)-- A new study published in Cell Reports found that a transcription factor called Slug serves as 'command central' for determining breast stem cell health, regulating both stem cell activity and repair of DNA damage. The research team also discovered that Slug likely functions as a safeguard against age-related decline of breast stem cell function.

Transcription factors are proteins that bind to DNA sequences and play a role in cancer. The research team previously reported that Slug plays a central role in some types of breast cancers. Building on their prior work, the researchers used breast cells from both humans and mice to explore how Slug might be helpful in maintaining cell fitness.

"These findings help us understand how Slug functions in normal breast tissue and how it may function in breast cancer," said breast cancer researcher Charlotte Kuperwasser at Tufts University School of Medicine. "Slug is overexpressed in a subtype of breast cancer called basal-like breast cancer. If Slug is also critical for DNA damage repair mechanisms in basal-like breast cancers, it might increase the attractiveness of Slug as a therapeutic target."

The main function of stem cells in our bodies is to replenish tissues, and to do so, stem cells need to stay healthy. One of the most important ways stem cells do this is by efficiently repairing damaged DNA, as unrepaired damage can lead to mutations in DNA that disrupt normal stem cell behavior. Upon detecting DNA damage, stem cells activate checkpoints to prevent replication of damaged cells, and they only regain regenerative activity after damaged DNA has been properly repaired.

"Our previous work established that Slug is critical for stem cell activity in breast tissue, but we suspected that there was more to the story," said Kuperwasser. "In asking what other functions Slug might be performing in breast tissue, particularly with regard to maintaining cell fitness, we found something quite interesting, which is that Slug regulates breast stem cell function partially through DNA damage repair."

More specifically, the researchers found that Slug deficiency in human breast cells prevented recruitment of key proteins that are required for repairing DNA. This function of Slug appears to be independent of its role in regulating gene transcription.

While Kuperwasser and colleagues have yet to determine whether breast cancer cells utilize Slug's DNA damage repair function, their current study did make a connection between Slug's multifaceted roles in breast tissue and another biological process: aging.

As stem cells age, their ability to replicate and repair DNA damage decreases. The team found that breast tissue from aged mice had higher levels of DNA damage and lower stem cell activity. Importantly, these characteristics were also found in Slug-deficient breast tissue from young mice. The observation of these characteristics both in aged tissue and in young Slug-deficient breast tissue strongly suggests that Slug function is disrupted during aging. The precise mechanism of how that function is disrupted is still being investigated by the team.

"Our data point towards Slug acting as a safeguard against breast tissue aging, as it promotes both stem cell activity and efficient DNA damage repair, which are disrupted in aged breast tissue," said co-first author Kayla Gross, who did this work as part of her Ph.D. dissertation at the Sackler School of Graduate Biomedical Sciences at Tufts.

"But these 'fountain of youth' properties of Slug are certainly a double-edged sword. Breast cancer cells may keep themselves up and running by co-opting the stem cell activity and DNA repair activity of Slug. What will be most important going forward is understanding how Slug is regulated. How do aged cells turn off its functions? How do breast cancer cells turn them on?" continued Gross.
-end-
The co-first author is Wenhui Zhou, who did this work as part of his M.D./Ph.D. program at Tufts.

Additional authors are Jerrica L. Breindel, Quinnipiac University and former member of the NIH-funded Institutional Research Career and Academic Development Awards Program, Training in Education and Critical Research Skills, at Tufts (TEACRS-IRACDA); Jian Ouyang, of Massachusetts General Hospital Cancer Center; Dexter X. Jin and Ethan S. Sokol, formerly of the Gupta Lab at the Whitehead Institute for Biomedical Research; Lee Zou, Massachusetts General Hospital Cancer Center and Harvard Medical School; Piyush Gupta, MIT and Whitehead Institute; and Kathryn Huber, Tufts Medical Center and Tufts University School of Medicine.

This work was supported by awards from National Institutes of Health's National Institute of General Medical Sciences (R01GM124491), the Raymond and Beverly Sackler Convergence Laboratory, Find The Cause Breast Cancer Foundation, Breast Cancer Research Foundation, and Neuroendocrine Tumor Research Foundation. Please see the study for conflicts of interest. This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funders.

Gross, K. M., Zhou, W., Breindel, J. L., Ouyang, J., Jin, D. X., Sokol, E. S., Gupta, P.B., Huber, K., Zou, L., Kuperwasser, C. (2019). Loss of Slug compromises DNA damage repair and accelerates stem cell aging in mammary epithelium. Cell Reports, 28, 1-14. https://doi.org/10.1016/j.celrep.2019.06.043

Tufts University, Health Sciences Campus

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.